Crescenta Biosciences II develops immunometabolic modulators for treating age-related diseases and cancer. The company focuses on modulating the immune response by targeting biological functions associated with lipid binding proteins.
investor of
Metrics
marketPRIVATE
msh_idCOM:CRESCENTABIO
localeus
websitehttps://www.crescentabio.com
source_ref5cba908d-3c10-424b-80b4-fa01bf452021
products_or_servicesDevelopment of first-in-class drugs targeting lipid binding proteins for diseases and conditions that pose significant challenges to current medical practices
United States